A review of the use of maggots in wound therapy

Annals of Plastic Surgery

Volumn 60, Issue 2, 2008, Pages 224-227

  Gupta, Amit ^a,b  

^a LOK NAYAK HOSPITAL   (India)

^b L 7 GF ^*  (India)

Author keywords

Healing; Maggots; Wound debridement

Indexed keywords

ANTIBACTERIAL ACTIVITY; COST EFFECTIVENESS ANALYSIS; DEBRIDEMENT; EPITHELIUM; HOUSE FLY; LARVA; LIFE CYCLE; MAGGOT; MAGGOT THERAPY; MYIASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; WOUND CARE; WOUND HEALING;

ANIMALS; DEBRIDEMENT; LARVA; WOUND HEALING; WOUND INFECTION;

EID: 38549170386     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e318053eb5e     Document Type: Review

References (34)

1. Trudgian JRN. Evaluating the benefits of larval therapy. Nurs Stand. 2002;16:65-72.
2. Reinecke M, Mayer G, Heisig P. Lucilia sericata: latest results of antibacterial activity: P1054 [15th European Congress of Clinical Microbiology and Infectious Diseases Copenhagen, Denmark 2-5 April 2005: Wound and fungal infections]. Clin Microbiol Infect Suppl. 2005;11(suppl 2):327-328.
3. Wollina L, Karte K, Herold C, et al. Biosurgery in wound healing - the renaissance of maggot therapy. J Eur Acad Dermatol Venereol. 2000;14:285-289.
4. Baer WS. The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). J Bone Joint Surg. 1931;13:438-475.
5. Chain E, Florey HW, Gardner AD, et al. Penicillin as a chemotherapeutic agent. Lancet. 1940;2:226-228.
6. Nigam Y, Bexfield A, Thomas S, et al. Maggot therapy: the science and implication for CAM, part I: history and bacterial resistance. Evid Based Complement Alternat Med. 2006;3:223-227. Published online 2006, May 5. doi: 10.1093/ecam/nel021.
7. Galaeno M, Ioli V, Colonna M, et al. Maggot therapy for treatment of osteomyelitis and deep wounds: an old remedy for an actual problem. Plast Reconstr Surg. 2001;108:2178-2179.
8. 7a. Church JC, Courtenay M. Maggot debridement therapy for chronic wounds. Int J Low Extrem Wounds. 2002;1:129-134.
9. Courteney M, Church JCT, Ryan TJ. Larva therapy in wound management. J R Soc Med. 2000;93:72-74.
10. Steenvoorde P, Buddingh TJ, van Engeland A, et al. Maggot therapy and the "yuk" factor: an issue for the patient? Wound Repair Regen. 2005;13:350-352.
11. Fitzpatrick M. Tiny "surgeons" prove surprisingly effective. JAMA. 2000;284:2306 -2307.
12. Greer KA. Maggots: age-old therapy gets new approval. Home Health Nurs. 2005;23:419-420.
13. Attinger C, Janis JE, Steinberg J, et al. Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg. 2006;117(suppl): 72S-109S.
14. Broughton G, Janis JE, Attinger CE, et al. A brief history of wound care. Plast Reconstr Surg. 2006;117(suppl):6S-11S.
15. Kirshen C, Woo K, Ayello EA, et al. Debridement: a vital component of wound bed preparation. Adv Skin Wound Care 2006;19:506-517.
16. Robinson W, Norwood VH. The role of surgical maggots in the disinfection of osteomyelitis and other infected wounds. J Bone Joint Sur. 1933;15:409-412.
17. Jukema GN, Wong CY, Steenvoorde P, et al. New approach in trauma surgery: can maggots reduce invalidating amputations in case of serious injury with severe infection? Abstract 411. 15th Annual Meeting of the European Tissue Repair Society: Stuttgart 2005: Kultur & Kongresszentrum Liederhalle: Stuttgart, Germany: September 14-17, 2005: Clinical Studie. Wound Repair Regen. 2006;14:A31-A32.
18. Jones MBN. Larval therapy. Nurs Stand. 2000;14:47-51.
19. Mumcuoglu KY, Ingber A, Gilead L, et al. Maggot therapy for the treatment of diabetic foot ulcers. Diabetes Care. 1998;21:2030-31.
20. 18a. Wolff H, Hansson C. Larval therapy- an effective method of ulcer debridement. Clin Exp Dermatol. 2003;28:134-137.
21. Wollina U, Liebold K, Schmidt W-D, et al. Biosurgery supports granulation and debridement in chronic wounds: clinical data and remittance spectroscopy measurement. Int J Dermatol. 2002;41:635-639.
22. Simmons SW. A bactericidal principle in excretions of surgical maggots which destroys important etiological agents of pyogenic infections. Bacteriology. 1935;30:253-267.
23. Daeschlein G, Mumcuoglu KY, Assadian O, et al. In vitro antibacterial activity of Lucilia sericata maggot secretions. Skin Pharmacol Physiol. 2006;20:112-115.
24. Bonn D. Maggot therapy: an alternative for wound infection. Lancet. 2000;356:1174.
25. Margolin LB. Abex: assessment of the antimicrobial properties of maggots. Am J Phys Med Rehabil. 2005;84:223.
26. Sherman RA. Maggot versus conservative debridement therapy for treatment of pressure ulcers. Wound Repair Regen. 2002;10:208-214.
27. Sherman RA. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care 2003;26:446-451.
28. Thomas S. New treatment for diabetic foot ulcers. In: Boulton A, Connor H, Cavanagh P, eds. The Foot in Diabetes. 3rd ed. England: John Wiley & Sons; 2002.
29. Courtenay M, Church JCT, Ryan TJ. Larva therapy in wound management. J R Soc Med. 2000;98:72-74.
30. Sherman RA. A new dressing design for use with maggot therapy. Plast Reconstr Surg. 1997;100:451-456.
31. Thomas S. Cost of managing chronic wounds in the UK, with particular emphasis on maggot debridement therapy. J Wound Care. 2006;15:465-469.
32. Wayman J, Nirojogi V, Walker A, et al. The cost effectiveness of larval therapy in venous ulcers. J Tissue Viability. 2000;10:91-95.
33. Jarvis A. Maggot therapy. Lancet. 2000;356:2016.
34. Sherman RA, Sherman J, Gilead L, et al. Maggot debridement therapy in outpatients. Arch Phys Med Rehabil. 2001;82.